{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T18:13:05Z","timestamp":1764785585460,"version":"3.43.0"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2,21]]},"abstract":"<jats:p>This study utilized proton magnetic resonance spectroscopy (1H-MRS) to analyze changes in glutamate-to-creatine ratios (Glu\/Cr) in specific brain regions of patients with subjective cognitive decline (SCD) and explored their clinical value for early diagnosis and intervention. Sixty participants, including 30 SCD patients and 30 healthy controls (HCs), were enrolled. Brain imaging was performed using a 3.0T superconducting magnetic resonance scanner. Single-voxel point-resolved spectroscopy sequence (PRESS) was applied for 1H-MRS, focusing on the left posterior cingulate gyrus, hippocampus, and temporal lobe. Glu\/Cr ratios were calculated and compared between groups. Correlations between Glu\/Cr ratios and cognitive function scores were analyzed. Glu\/Cr ratios in the left posterior cingulate gyrus were significantly lower in the SCD group compared to the healthy control group (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.002), suggesting early metabolic disturbances in this region. However, no significant differences in Glu\/Cr ratios were observed in the left hippocampus (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.312) or temporal lobe (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u2005.073). Additionally, the Glu\/Cr ratio in the posterior cingulate gyrus negatively correlated with cognitive function scores (r\u2005=\u2005\u22120.45, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.001), further emphasizing its potential as a biomarker for early cognitive impairment. This study highlights the diagnostic value of reduced Glu\/Cr ratios in the posterior cingulate gyrus for identifying SCD patients at risk of cognitive decline. The findings support the application of 1H-MRS as a noninvasive tool for early detection and monitoring of metabolic changes associated with neurodegenerative processes. Future longitudinal studies are needed to confirm these findings and explore their utility in guiding clinical interventions.<\/jats:p>","DOI":"10.1097\/md.0000000000041474","type":"journal-article","created":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T15:02:54Z","timestamp":1740409374000},"page":"e41474","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Early diagnostic value of neurotransmitter changes in vulnerable brain regions of patients with subjective cognitive decline detected using proton magnetic resonance spectroscopy"],"prefix":"10.1097","volume":"104","author":[{"given":"Zhen","family":"Zeng","sequence":"first","affiliation":[{"name":"Department of Neurology, Wuhan Third Hospital, Wuhan, Hubei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"He","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wuhan Third Hospital, Wuhan, Hubei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-2946-0549","authenticated-orcid":false,"given":"Tao","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Neurology, Wuhan Third Hospital, Wuhan, Hubei, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250805","doi-asserted-by":"crossref","first-page":"1382381","DOI":"10.3389\/fphar.2024.1382381","article-title":"Hippocampal region metabolites and cognitive impairment in patients with general paresis: based on 1h-proton magnetic resonance spectroscopy.","volume":"15","author":"Che","year":"2024","journal-title":"Front Pharmacol"},{"key":"R2-20250805","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.wneu.2019.12.162","article-title":"Application of hydrogen proton magnetic resonance technology combined with brain neurometabolite analysis in the treatment of cognitive impairment caused by type 2 diabetes mellitus.","volume":"138","author":"Li","year":"2020","journal-title":"World Neurosurgery"},{"key":"R3-20250805","doi-asserted-by":"crossref","first-page":"103159","DOI":"10.1016\/j.nicl.2022.103159","article-title":"1H-MRS neurometabolites and associations with neurite microstructures and cognitive functions in amnestic mild cognitive impairment.","volume":"36","author":"Gozdas","year":"2022","journal-title":"NeuroImage"},{"key":"R4-20250805","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2174\/1567205018666210708145924","article-title":"Longitudinal functional magnetic resonance spectroscopy study in subjects with mild cognitive impairment and Alzheimer\u2019s disease.","volume":"18","author":"Cho","year":"2021","journal-title":"Curr Alzheimer Res"},{"key":"R5-20250805","doi-asserted-by":"crossref","first-page":"4074","DOI":"10.21037\/qims-20-1254","article-title":"Brain neurometabolites differences in individuals with subjective cognitive decline plus: a quantitative single-and multi-voxel proton magnetic resonance spectroscopy study.","volume":"11","author":"Yang","year":"2021","journal-title":"Quantitative Imaging Me Surg"},{"key":"R6-20250805","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s10072-020-04626-9","article-title":"Frontal lobe metabolic alterations characterizing Parkinson\u2019s disease cognitive impairment.","volume":"42","author":"Chaudhary","year":"2021","journal-title":"Neurol Sci"},{"key":"R7-20250805","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.acra.2020.06.006","article-title":"Cerebrospinal fluid amyloid beta, Tau levels, apolipoprotein, and 1H-MRS brain metabolites in Alzheimer\u2019s disease: a systematic review.","volume":"28","author":"Piersson","year":"2021","journal-title":"Acad Radiol"},{"key":"R8-20250805","doi-asserted-by":"crossref","first-page":"103459","DOI":"10.1016\/j.nicl.2023.103459","article-title":"Progressive myoclonic epilepsy type 1 (EPM1) patients present with abnormal 1H MRS brain metabolic profiles associated with cognitive function.","volume":"39","author":"Hypp\u00f6nen","year":"2023","journal-title":"NeuroImage"},{"key":"R9-20250805","doi-asserted-by":"crossref","first-page":"8149","DOI":"10.1523\/JNEUROSCI.2883-19.2020","article-title":"Regional myo-inositol, creatine, and choline levels are higher at older age and scale negatively with visuospatial working memory: a cross-sectional proton MR spectroscopy study at 7 Tesla on normal cognitive ageing.","volume":"40","author":"Lind","year":"2020","journal-title":"J Neurosci"},{"key":"R11-20250805","doi-asserted-by":"crossref","first-page":"936130","DOI":"10.3389\/fped.2022.936130","article-title":"A correlation between magnetic resonance spectroscopy (1-H MRS) and the neurodevelopment of two-year-olds born preterm in an EPIRMEX cohort study.","volume":"10","author":"Gire","year":"2022","journal-title":"Front Pediatr"},{"key":"R12-20250805","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000508098","article-title":"Magnetic resonance spectroscopy following mild traumatic brain injury: a systematic review and meta-analysis on the potential to detect posttraumatic neurodegeneration.","volume":"20","author":"Eisele","year":"2020","journal-title":"Neurodegenerative Dis"},{"key":"R13-20250805","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1038\/s41380-023-02079-y","article-title":"Neurometabolite levels in the brains of patients with autism spectrum disorders: A meta-analysis of proton magnetic resonance spectroscopy studies (N= 1501).","volume":"28","author":"Du","year":"2023","journal-title":"Mol Psychiatry"},{"key":"R14-20250805","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/arclin\/acab033","article-title":"The relationship between brain metabolites alterations and neuropsychological deficits in patients with methamphetamine use disorder: a proton magnetic resonance spectroscopy study.","volume":"37","author":"Bakhshinezhad","year":"2022","journal-title":"Arch Clin Neuropsychol"},{"key":"R15-20250805","doi-asserted-by":"crossref","first-page":"e20534","DOI":"10.1016\/j.heliyon.2023.e20534","article-title":"Effects of acute physical activity on brain metabolites as measured by magnetic resonance spectroscopy (1H-MRS) in humans: a systematic review.","volume":"9","author":"Ryberg","year":"2023","journal-title":"Heliyon"},{"key":"R16-20250805","first-page":"571","article-title":"Hippocampal metabolic alterations in amyotrophic lateral sclerosis: a magnetic resonance spectroscopy study.","volume":"13","author":"Christidi","year":"2023","journal-title":"Life (Basel)"},{"key":"R17-20250805","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s41390-021-01539-x","article-title":"Brain proton magnetic resonance spectroscopy and neurodevelopment after preterm birth: a systematic review.","volume":"91","author":"Cebeci","year":"2022","journal-title":"Pediatr Res"},{"key":"R18-20250805","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/9781119057840.ch18","article-title":"Magnetic resonance spectroscopy (mrs) in psychiatric diseases.","volume":"18","author":"Lin","year":"2020","journal-title":"Wiley Encyclopedia Health Psychol"},{"key":"R19-20250805","first-page":"1790","article-title":"The brain metabolic signature in superagers using in vivo 1H-MRS: a pilot study.","volume":"42","author":"de Godoy L","year":"2021","journal-title":"Am J Neuroradiol"},{"key":"R20-20250805","doi-asserted-by":"crossref","first-page":"103273","DOI":"10.1016\/j.ajp.2022.103273","article-title":"Neurochemical correlates of cognitive functions in euthymic patients with bipolar disorder: 1H-MRS study.","volume":"78","author":"Gupta","year":"2022","journal-title":"Asian J Psychiatry"},{"key":"R21-20250805","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/13651501.2019.1699118","article-title":"Proton magnetic resonance spectroscopic analysis of changes in brain metabolites following electroconvulsive therapy in patients with major depressive disorder.","volume":"24","author":"Tosun","year":"2020","journal-title":"Int J Psychiatry Clin Pract"},{"key":"R22-20250805","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1093\/infdis\/jiad309","article-title":"Neuronal and glial metabolite abnormalities in participants with persistent neuropsychiatric symptoms after COVID-19: a brain proton magnetic resonance spectroscopy study.","volume":"228","author":"Ernst","year":"2023","journal-title":"J Infect Dis"},{"key":"R23-20250805","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neurobiolaging.2021.12.010","article-title":"1H MR spectroscopy biomarkers of neuronal and synaptic function are associated with tau deposition in cognitively unimpaired older adults.","volume":"112","author":"Kara","year":"2022","journal-title":"Neurobiol Aging"},{"key":"R24-20250805","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2463\/mrms.rev.2021-0055","article-title":"1H-MR Spectroscopy of the early developmental Brain, neonatal encephalopathies, and neurometabolic disorders.","volume":"21","author":"Aida","year":"2022","journal-title":"Magnetic Resonance Med Sci"},{"key":"R25-20250805","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jalz.2008.04.008","article-title":"Brain metabolism differs in Alzheimer\u2019s disease and Parkinson\u2019s disease dementia.","volume":"4","author":"Griffith","year":"2008","journal-title":"Alzheimers Dement"},{"key":"R26-20250805","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.jagp.2019.02.017","article-title":"Lamotrigine therapy and biomarkers of cerebral energy metabolism in older age bipolar depression.","volume":"27","author":"Mellen","year":"2019","journal-title":"Am J Geriatr Psychiatry"},{"key":"R27-20250805","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1007\/s00213-013-3354-8","article-title":"Glutamate, N-acetyl aspartate and psychotic symptoms in chronic ketamine users [published correction appears in Psychopharmacology (Berl). 2014 May;231(10):2117-8].","volume":"231","author":"Stone","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"R28-20250805","first-page":"997","article-title":"Identification of metabolic correlates of mild cognitive impairment in Parkinson\u2019s disease using magnetic resonance spectroscopic imaging and machine learning.","volume":"35","author":"Cengiz","year":"2022","journal-title":"Magma (New York, N.Y.)"},{"key":"R29-20250805","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2021.09.016","article-title":"Relationships between frontal metabolites and Alzheimer\u2019s disease biomarkers in cognitively normal older adults.","volume":"109","author":"Hone-Blanchet","year":"2022","journal-title":"Neurobiol Aging"},{"key":"R30-20250805","doi-asserted-by":"crossref","first-page":"e1917363","DOI":"10.1001\/jamanetworkopen.2019.17363","article-title":"Racial disparity in cerebrospinal fluid amyloid and tau biomarkers and associated cutoffs for mild cognitive impairment.","volume":"2","author":"Garrett","year":"2019","journal-title":"JAMA Netw Open"},{"key":"R31-20250805","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.3233\/JAD-215431","article-title":"Frontal metabolites and Alzheimer\u2019s disease biomarkers in healthy older women and women diagnosed with mild cognitive impairment.","volume":"87","author":"Hone-Blanchet","year":"2022","journal-title":"J Alzheimer's Dis"},{"key":"R32-20250805","doi-asserted-by":"crossref","first-page":"102220","DOI":"10.1016\/j.ajp.2020.102220","article-title":"Metabolite abnormalities in psychosis risk: a meta-analysis of proton magnetic resonance spectroscopy studies.","volume":"54","author":"Wang","year":"2020","journal-title":"Asian J Psychiatry"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041474","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:24:00Z","timestamp":1754414640000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000041474"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000041474","relation":{},"ISSN":["1536-5964"],"issn-type":[{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2025,2,21]]}}}